—>
Main Menu

Funding for new treatment

NovaBiotics secures DHSC grant for fungal treatment

Deborah ONeilDrugs development firm NovaBiotics has secured a £1.8million grant as part of a Department of Health and Social Care research competition aimed at tackling fungal infections.

The project aims to transform the Aberdeen firm’s Novamycin treatment from the laboratory to a drug ready for clinical testing. This would represent a potential breakthrough in advancing Novamycin further towards addressing the significant need for new, safe, effective and therapies for life-threatening invasive fungal infections. 

The grant was made as part of a £10m Small Business Research Initiative (SBRI) competition run by Innovate UK on behalf of DHSC.

Dr Deborah O’Neil, pictured, CEO of NovaBiotics, said: “This award allows us to accelerate the next key stage of Novamycin’s development towards being a much-needed solution to life threatening fungal infections against which the limited number of existing therapies are ineffective.”

Dr Kath Mackay, interim director, Ageing Society, Health & Nutrition, Innovate UK said the work being undertaken is one of the biggest global challenges in healthcare.



Leave a Reply

Your email address will not be published. Required fields are marked as *

This site uses Akismet to reduce spam. Learn how your comment data is processed.